Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 52,396 shares at $50.07 ($2.6M) on 2026-03-25, disclosed to the SEC on 2026-03-27.
Scheduled sale ($2.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.07 | 26,198 | $1.3M | 50.0% |
| 2 | $50.07 | 26,198 | $1.3M | 50.0% |
| Total | $50.07 avg | 52,396 | $2.6M | 100% |
| Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |
| CORT | SELL | 2025-10-03 | $6.8M | — | Filing → |